Latest Share Chat

REMOVE ADS

Astrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

14,318.00 256.00 (1.82%)

Bid:

14,256.00

Ask:

14,262.00

Spread: 6.00 (0.042%)

Market Cap: £222.05b

Last checked at -

Intraday Astrazeneca Share Chart

REMOVE ADS

Astrazeneca News

AstraZeneca flags positive trial data for Saphnelo as SLE treatment

(Alliance News) - AstraZeneca PLC on Tuesday said a Saphnelo self-administration Thlip-SC trial demonstrated statistically significant and clinically ...

Hutchmed savolitinib NDA for gastric cancer accepted in China

(Alliance News) - Hutchmed China Ltd on Tuesday said Chinese regulators have accepted and granted priority review to its new drug application for savo...

London's FTSE 100 closes lower in shortened Christmas Eve session

FTSE 100 down 0.2%; FTSE 250 ⁠down ‌0.07% *

LONDON MARKET CLOSE: FTSE fails to sparkle in tame pre-holiday trade

(Alliance News) - The FTSE 100 drifted lower on Wednesday in lacklustre trading ahead of the Christmas break, although a chunky disposal by BP brought...

LONDON MARKET OPEN: FTSE mixed in shortened Christmas Eve trade

(Alliance News) - Stock prices in London opened modestly lower on Wednesday, during a shortened trading session ahead of the Christmas holiday break.

Novo Nordisk shares jump almost 8% after US approves Wegovy pill

Novo Nordisk first to ⁠market with Wegovy pill *

AstraZeneca says lung cancer trial fails to meet survival target

(Alliance News) - AstraZeneca PLC on Monday said a phase three trial in a potential treatment for a form of non-small cell lung cancer failed to meet ...

AstraZeneca's ceralasertib-Imfinzi drug combo misses survival target in lung cancer trial

Phase III trial involved 594 patients ⁠across 20 ‌countries *